Latest News in the pharma Industry

Market News

Regeneron and Sanofi begin global Kevzara clinical trial program in patients with severe COVID-19

Regeneron and Sanofi begin global Kevzara clinical trial program in patients with severe COVID-19

16 Mar 2020

The trial is the first controlled trial in the US to evaluate the effect of IL-6 inhibition prospectively in COVID-19 patients.

Read more 
Contec launches virtual training tool sensitive to social distancing

Contec launches virtual training tool sensitive to social distancing

16 Mar 2020

A web-based means of finding the cleaning products to meet the challenges posed by cleanroom operations.

Read more 
Mylan launches first bioequivalent alternative to Advair Diskus in Canada

Mylan launches first bioequivalent alternative to Advair Diskus in Canada

10 Mar 2020

Appropriate asthma and COPD patients provided with a "more affordable alternative to appropriate".

Read more 
FDA approves Pharming's new facility for expanded Ruconest production

FDA approves Pharming's new facility for expanded Ruconest production

10 Mar 2020

Netherlands-based specialty pharmaceutical company Pharming has received US Food and Drug Administration (FDA) approval for its new biologics facility in the Netherlands which it says will ensure sufficient manufacturing capacity for its acute heredita...

Read more 
Sartorius simplifies biologics production with new bioreactor

Sartorius simplifies biologics production with new bioreactor

9 Mar 2020

Company launches BIOSTAT STR Generation 3 bioreactor with BIOBRAIN automation platform.

Read more 
Bristol Myers Squibb disappointed with failed late-stage combo drug trial

Bristol Myers Squibb "disappointed" with failed late-stage combo drug trial

9 Mar 2020

Phase III study evaluating Empliciti plus Revlimid and dexamethasone in patients with newly diagnosed, untreated multiple myeloma fails to meet primary endpoint.

Read more 
Nanoform and Orion collaborate on 'nanoformed' APIs

Nanoform and Orion collaborate on 'nanoformed' APIs

9 Mar 2020

Active pharmaceutical ingredients (APIs) nanoformed using the CESS process demonstrate promise for overcoming solubility and bioavailability challenges.

Read more 
Bora Pharmaceuticals to buy GSK's Mississauga-based manufacturing facility

Bora Pharmaceuticals to buy GSK's Mississauga-based manufacturing facility

9 Mar 2020

CDMO Bora Pharmaceuticals said Monday it has agreed to acquire GlaxoSmithKline's Mississauga, Ontario (Canada) facility, which produces approximately 50 different products for more than 100 markets worldwide.

Read more 
Thermo Fisher Scientific to acquire Qiagen

Thermo Fisher Scientific to acquire Qiagen

3 Mar 2020

Thermo Fisher Scientific said Tuesday it has agreed to buy Dutch molecular testing and diagnostics specialist Qiagen for €39 per share in cash, valuing the overall transaction at around USD 11.5 billion.

Read more 
Gilead to boost R&D pipeline with $4.9 billion deal for Forty Seven

Gilead to boost R&D pipeline with $4.9 billion deal for Forty Seven

3 Mar 2020

Biotech firm Gilead Sciences said Monday it is set to acquire clinical-stage oncology specialist Forty Seven in a transaction worth $4.9 billion.

Read more 
MindMed becomes world's first psychedelic pharma company to go public

MindMed becomes world's first psychedelic pharma company to go public

3 Mar 2020

The company’s immediate priority is to address the opioid crisis by developing a non-hallucinogenic version of the psychedelic ibogaine.

Read more 
Jim Miller joins C2 Pharma advisory board

Jim Miller joins C2 Pharma advisory board

3 Mar 2020

Luxembourg-based phytochemical and chemical pharmaceutical manufacturing and distribution group, C2 Pharma, has expanded its advisory board with a new member.

Read more